neurocrine.com (NBIX): Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization

Graphic logo of neurocrine.com (NBIX)

Neurocrine Biosciences (NBIX) minimizes patent risks through the variability of its clinical programs in endocrinology and neurology. Drug safety is guaranteed by strict adherence to temperature controls during transportation. The commercial success of Ingrezza and a powerful R&D sector create a defensive barrier. The EV/EBITDA multiple of this capital-intensive enterprise confirms these data, and the mark 16.55 characterizes this parameter.

NBIX Neurocrine: Company Value to EBITDA in the range 11/23/2025 - 11/17/2026

Comprehensive metric breakdowns and analytics for Neurocrine Biosciences, Inc. (NBIX)

- stock price and consensus target price:
Comprehensive company analysis:NBIX (Neurocrine Biosciences, Inc.)
Original product of neurocrine.com

Neurocrine Biosciences (NBIX) develops high-margin drugs with lifelong demand, rendering the business resilient to market volatility. The enterprise value to EBITDA ratio allows for an assessment of this asset's scale by excluding the impact of debt load and tax regimes. The investor utilizes this metric to filter short-term noise from long-term trends. By analyzing the EV/EBITDA trend over time, one can avoid purchasing overvalued assets.

Competitor analysis for Neurocrine Biosciences

Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Biogen Inc BIIB|regencellbioscience.com (RGC) - Company Value to EBITDA|AXSM - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|ACAD (ACADIA Pharmaceuticals Inc.) - Enterprise Value to Operating Income Before Depreciation|Xenon Pharmaceuticals (XENE) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Enterprise Value to Operating Income Before Depreciation VKTX|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Supernus|Company Value to EBITDA catalystpharma.com CPRX|Enterprise Value to EBITDA Ratio DNLI (Denali Therapeutics Inc.)|HRMY - Company Value to EBITDA|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Biohaven Ltd. BHVN|AMLX (Amylyx) - Company Value to Operating Income Before Depreciation Ratio|Trevi Therapeutics Inc - EV/EBITDA Multiple|Business Value to Operating Income Before Depreciation PRAX (Praxis Precision Medicines)|AVXL: EV/EBITDA Multiple|CBLL - Total Company Value to Operating Income Before Depreciation Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization prothena.com|Enterprise Value to EBITDA Ratio Alector (ALEC)|Enterprise Value to EBITDA Ratio ANNX (annexonbio.com)|OMER - Company Value to EBITDA|EV/EBITDA Multiple NGNE (Neurogene Inc)|EV/EBITDA Multiple AC Immune S.A. ACIU|VYGR - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Company Value to Operating Income Before Depreciation Ratio NMRA|SCLX (Scilex Holding Company) - Enterprise Value to EBITDA Ratio|TVGN (Tevogen Bio Holdings) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|ACOG (Alpha Cognition Corp) - EV/EBITDA Multiple|Cognition Therapeutics, Inc. - Company Value to Operating Income Before Depreciation Ratio|EV/EBITDA Multiple IKT|SAVA (Cassava) - Business Value to Operating Income Before Depreciation|Assertio Holdings, Inc. - Enterprise Value to EBITDA Ratio|Business Value to Operating Income Before Depreciation COYA|VistaGen Therapeutics, Inc. - EV/EBITDA Multiple|Total Company Value to Operating Income Before Depreciation Ratio Ovid Therapeutics OVID|ABOS: EV/EBITDA Multiple|CervoMed Corporation (CRVO) - EV/EBITDA Multiple|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Alterity Therapeutics Limited|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization CLNN|EV/EBITDA Multiple PEPG|JUNS (Jupiter Neurosciences) - Business Value to Operating Income Before Depreciation|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Relmada Corp RLMD|EV/EBITDA Multiple Annovis Bio Corporation ANVS|gracetx.com - EV/EBITDA Multiple|Firefly Neuroscience, Inc (AIFF) - Enterprise Value to EBITDA Ratio|Klotho Neurosciences (KLTO) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|NeuroSense Therapeutics, Ltd. - Business Value to Operating Income Before Depreciation|RVPH (Reviva Pharmaceuticals Holdings) - EV/EBITDA Multiple|MetaVia Inc (MTVA) - Total Company Value to Operating Income Before Depreciation Ratio|EV/EBITDA Multiple NRXS|Total Company Value to Operating Income Before Depreciation Ratio Helius Medical Technologies Inc.|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization passagebio.com PASG|NEUP: Enterprise Value to Operating Income Before Depreciation|NERV - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Athira - Enterprise Value to Operating Income Before Depreciation Ratio|ADXN: EV/EBITDA Multiple|ALZN (Alzamend Neuro, Inc.) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Cyclerion Therapeutics Inc.|PTIX: Business Value to Operating Income Before Depreciation|EV/EBITDA Multiple KTTA|Enterprise Value to Operating Income Before Depreciation Ratio CRGT|Avenue Therapeutics Inc - Enterprise Value to EBITDA Ratio|Business Value to Operating Income Before Depreciation BCLI|CARA - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Business Value to Operating Income Before Depreciation CHRO (Chromocell Therapeutics Corp)|ELYM: EV/EBITDA Multiple|Enterprise Value to Operating Income Before Depreciation ITCI|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Longboard Pharmaceuticals Inc|marinuspharma.com (MRNS) - Total Company Value to Operating Income Before Depreciation Ratio|Enterprise Value to EBITDA Ratio NKGN (NKGen Biotech, Inc.)|NRBO - Company Value to EBITDA|EV/EBITDA Multiple SAGE (Sage Therapeutics, Inc)|SNPX: Enterprise Value to Operating Income Before Depreciation|Trevena Inc. - EV/EBITDA Multiple|Total Company Value to Operating Income Before Depreciation Ratio vigilneuro.com VIGL|WENA: EV/EBITDA Multiple|Company Value to EBITDA Cerevel Therapeutics Inc (CERE)